Approval · Notice of Compliance 1714 · 2003
LOVASTATIN: Notice of Compliance 1714
Issued April 30, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1714
- Date
- April 30, 2003
- Company
- Prempharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Lipid metabolism regulator
- Canadian reference product
- MEVACOR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOVASTATIN | 02247536 | — |
| LOVASTATIN | 02247537 | — |
Medicinal ingredients
- LOVASTATIN 20 MG per TAB
- LOVASTATIN 40 MG per TAB